224 related articles for article (PubMed ID: 28630196)
21. Susceptibility of Staphylococcus aureus to topical agents in the United States: a sentinel study.
Biedenbach DJ; Bouchillon SK; Johnson SA; Hoban DJ; Hackel M
Clin Ther; 2014 Jun; 36(6):953-60. PubMed ID: 24835558
[TBL] [Abstract][Full Text] [Related]
22. Evaluating the antibacterial activity of ceftaroline against clinical isolates of methicillin-susceptible and- resistant Staphylococcus aureus in Kuwait hospitals.
Alfouzan W; Boswihi SS; Dhar R; Udo E
J Infect Public Health; 2020 Oct; 13(10):1589-1591. PubMed ID: 32859552
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous.
Liu Y; Kong F; Zhang X; Brown M; Ma L; Yang Y
Br J Dermatol; 2009 Dec; 161(6):1347-50. PubMed ID: 19754868
[TBL] [Abstract][Full Text] [Related]
24. [Genetic characterization and antimicrobial susceptibility analysis of methicillin-resistant Staphylococcus aureus isolated from ready-to-eat food and pig-related sources in China].
Wang W; Guo Y; Pei X; Hu Y; Bai L; Sun A; Liu J; Fu P; Li F
Wei Sheng Yan Jiu; 2013 Nov; 42(6):925-31. PubMed ID: 24459903
[TBL] [Abstract][Full Text] [Related]
25. Activity of Debio1452, a FabI inhibitor with potent activity against Staphylococcus aureus and coagulase-negative Staphylococcus spp., including multidrug-resistant strains.
Flamm RK; Rhomberg PR; Kaplan N; Jones RN; Farrell DJ
Antimicrob Agents Chemother; 2015 May; 59(5):2583-7. PubMed ID: 25691627
[TBL] [Abstract][Full Text] [Related]
26.
Guzek A; Rybicki Z; Tomaszewski D
Indian J Med Microbiol; 2018; 36(1):119-120. PubMed ID: 29735840
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals.
Andrey DO; François P; Manzano C; Bonetti EJ; Harbarth S; Schrenzel J; Kelley WL; Renzoni A
Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):343-350. PubMed ID: 27744604
[TBL] [Abstract][Full Text] [Related]
28. [In vitro activity of ceftaroline to MRSA isolates: a multicenter study].
Mengeloğlu FZ; Taş T; Koçoğlu E; Copur Çiçek A; Yanık K; Güneş H; Ciftci IH; Durmaz S; Bucak O; Güçkan R; Terzi HA; Yavuz MZ
Mikrobiyol Bul; 2013 Oct; 47(4):677-83. PubMed ID: 24237436
[TBL] [Abstract][Full Text] [Related]
29. Ceftaroline activity against bacterial pathogens frequently isolated in U.S. medical centers: results from five years of the AWARE surveillance program.
Sader HS; Flamm RK; Streit JM; Farrell DJ; Jones RN
Antimicrob Agents Chemother; 2015 Apr; 59(4):2458-61. PubMed ID: 25645844
[TBL] [Abstract][Full Text] [Related]
30. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
Lawrence KR; Golik MV; Davidson L
Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
[TBL] [Abstract][Full Text] [Related]
31. Antibiotics for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: the challenge of outpatient therapy.
Pate AJ; Terribilini RG; Ghobadi F; Azhir A; Barber A; Pearson JM; Kalantari H; Hassen GW
Am J Emerg Med; 2014 Feb; 32(2):135-8. PubMed ID: 24238483
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010-2012).
Flamm RK; Farrell DJ; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):449-56. PubMed ID: 24529941
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial susceptibility pattern of Staphylococcus aureus isolates from clinical specimens at Kenyatta National Hospital.
Gitau W; Masika M; Musyoki M; Museve B; Mutwiri T
BMC Res Notes; 2018 Apr; 11(1):226. PubMed ID: 29615129
[TBL] [Abstract][Full Text] [Related]
34. Frequency and antimicrobial susceptibility of bacterial isolates from patients hospitalised with community-acquired skin and skin-structure infection in Europe, Asia and Latin America.
Sader HS; Streit JM; Carvalhaes CG; Huband MD; Pfaller MA
J Glob Antimicrob Resist; 2019 Jun; 17():103-108. PubMed ID: 30458298
[TBL] [Abstract][Full Text] [Related]
35.
Gaikwad V; Gohel T; Panickar S; Chincholkar V; Mangalkar S
Indian J Pathol Microbiol; 2016; 59(4):496-498. PubMed ID: 27721280
[TBL] [Abstract][Full Text] [Related]
36. MRSA rates and antibiotic susceptibilities from skin and soft tissue cultures in a suburban ED.
Wackett A; Nazdryn A; Spitzer E; Singer AJ
J Emerg Med; 2012 Oct; 43(4):754-7. PubMed ID: 22494599
[TBL] [Abstract][Full Text] [Related]
37. Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE Program, 2009-2011.
Flamm RK; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):437-42. PubMed ID: 24582578
[TBL] [Abstract][Full Text] [Related]
38. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN
Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304
[TBL] [Abstract][Full Text] [Related]
39. Staphylococcus aureus antibiotic susceptibility patterns in pediatric atopic dermatitis.
Briscoe CC; Reich P; Fritz S; Coughlin CC
Pediatr Dermatol; 2019 Jul; 36(4):482-485. PubMed ID: 31124167
[TBL] [Abstract][Full Text] [Related]
40. [In vitro activity of ceftaroline against Spanish isolates of Staphylococcus aureus: a multicenter study].
Tenorio-Abreu A; Gil Tomás J; Bratos Pérez MÁ; de la Iglesia Salgado A; Borrás Máñez M; Ortiz de Lejarazu Leonardo R; Ávila Alonso A; Colomina Rodríguez J; Pérez Cáceres JA; Saavedra Martín JM; Márquez Sanabria A; Domínguez Castaño A; de la Iglesia Salgado M
Enferm Infecc Microbiol Clin; 2015 Feb; 33(2):101-4. PubMed ID: 25091384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
